Biography

Dr Metcalf is a Medical Oncologist at The Christie Hospital and Honorary Reader at The University of Manchester. He treats patients with Head and Neck Cancers with an academic focus on Salivary Gland Cancers.

Dr Metcalf was awarded his Medical Degree (MBChB) at the University of Manchester in 2004, during which he was awarded a First Class BSc in Health Care Ethics and Law. He became a Member of the Royal College of Physicians (UK) in 2007 and completed Medical Oncology Higher Specialist training in 2015.

Following Medical Oncology Specialist Training, he was awarded a PhD (2012 - 2016), following a Clinical Fellowship in the Clinical and Experimental Pharmacology Lab led by Prof Caroline Dive C.B.E. at the Cancer Research UK Manchester Institute. Durign his time studying circulating tumour cells as a 'liquid biopsy', he contributed to the development of new pre-clinical models of lung cancer.

Following the award of his PhD, Dr Metcalf undertook post-doctoral research in tumour-immunology in Head and Neck Cancers based in the Lydia Becker Institute of Immunology and Inflammation at the Universit of Manchetser under Prof Tracy Hussell. He is now the U.K. lead for Salivary Gland Cancer through the International Rare Cancers Initiative, a joint initiative through Cancer Research UK, EORTC and the US National Cancer Institute.

Since 2017 he has been supported through Academic Grants from the Manchester Cancer Research Centre (which comprises funding through Cancer Research UK, The University of Manchester and The Christie NHS) and the US based Adenoid Cystic Carcinoma Research Foundation and philanthropic grants from the Infrastructure Industry Foundation, Syncona Foundation, The Christie Charity as well as through donations by patients and their friends and families. 

His current research funding administered through the Christie Charity is the Ella Project, in memory of one of his patients who was instrumental in establishing the UK research program into Adenoid Cystic Carcinoma. He has also previously been awarded the prestigious University of Manchester Dean's Prize for Clinicians on two occasions which funded both his academic and clinical time and additional research costs to develop his leadership role in Salivary Gland Cancer Research.